1284 related articles for article (PubMed ID: 25134730)
21. Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons.
Wang J; Song N; Jiang H; Wang J; Xie J
Biochim Biophys Acta; 2013 May; 1832(5):618-25. PubMed ID: 23376588
[TBL] [Abstract][Full Text] [Related]
22. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
[TBL] [Abstract][Full Text] [Related]
23. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Kubo K; Inada T; Shingu K
Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
[TBL] [Abstract][Full Text] [Related]
24. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.
De Miranda BR; Popichak KA; Hammond SL; Miller JA; Safe S; Tjalkens RB
Toxicol Sci; 2015 Feb; 143(2):360-73. PubMed ID: 25406165
[TBL] [Abstract][Full Text] [Related]
25. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.
Frau L; Borsini F; Wardas J; Khairnar AS; Schintu N; Morelli M
Synapse; 2011 Mar; 65(3):181-8. PubMed ID: 20665698
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease.
Liang Y; Chen C; Xia B; Wu W; Tang J; Chen Q; Tang L; Yang H; Zhang Z; Lu Y; Yang Y; Zhao Y
Biomed Res Int; 2019; 2019():4379639. PubMed ID: 30834264
[TBL] [Abstract][Full Text] [Related]
28. The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes.
Zhao Q; Wu X; Yan S; Xie X; Fan Y; Zhang J; Peng C; You Z
J Neuroinflammation; 2016 Oct; 13(1):259. PubMed ID: 27716270
[TBL] [Abstract][Full Text] [Related]
29. Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
Zhao YF; Zhang Q; Xi JY; Li YH; Ma CG; Xiao BG
J Neurol Sci; 2015; 353(1-2):28-37. PubMed ID: 25908255
[TBL] [Abstract][Full Text] [Related]
30. Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models.
Benson MJ; Manzanero S; Borges K
Epilepsia; 2015 Jun; 56(6):895-905. PubMed ID: 25847097
[TBL] [Abstract][Full Text] [Related]
31. PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease.
Barbiero JK; Santiago R; Tonin FS; Boschen S; da Silva LM; Werner MF; da Cunha C; Lima MM; Vital MA
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():35-44. PubMed ID: 24593945
[TBL] [Abstract][Full Text] [Related]
32. Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.
Sadeghian M; Marinova-Mutafchieva L; Broom L; Davis JB; Virley D; Medhurst AD; Dexter DT
J Neuroimmunol; 2012 May; 246(1-2):69-77. PubMed ID: 22498097
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization.
Hasegawa-Moriyama M; Ohnou T; Godai K; Kurimoto T; Nakama M; Kanmura Y
Biochem Biophys Res Commun; 2012 Sep; 426(1):76-82. PubMed ID: 22910418
[TBL] [Abstract][Full Text] [Related]
35. Donepezil Regulates 1-Methyl-4-phenylpyridinium-Induced Microglial Polarization in Parkinson's Disease.
Chen T; Hou R; Xu S; Wu C
ACS Chem Neurosci; 2015 Oct; 6(10):1708-14. PubMed ID: 26114860
[TBL] [Abstract][Full Text] [Related]
36. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
37. Microglia-inhibiting activity of Parkinson's disease drug amantadine.
Kim JH; Lee HW; Hwang J; Kim J; Lee MJ; Han HS; Lee WH; Suk K
Neurobiol Aging; 2012 Sep; 33(9):2145-59. PubMed ID: 22035588
[TBL] [Abstract][Full Text] [Related]
38. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.
Reynolds AD; Banerjee R; Liu J; Gendelman HE; Mosley RL
J Leukoc Biol; 2007 Nov; 82(5):1083-94. PubMed ID: 17675560
[TBL] [Abstract][Full Text] [Related]
40. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Sriram K; Miller DB; O'Callaghan JP
J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
